TREA

79380366 - AUTOLUS

Follow

Information

  • Trademark
  • 79380366
  • Serial Number
    79380366
  • Registration Number
    7435787
  • Filing Date
    September 05, 2023
    a year ago
  • Registration Date
    July 09, 2024
    6 months ago
  • Transaction Date
    January 11, 2025
    17 days ago
  • Status Date
    July 09, 2024
    6 months ago
  • Published for Opposition Date
    April 23, 2024
    9 months ago
  • Location Date
    July 08, 2024
    6 months ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    STADELI, MARTA
  • Attorney Docket Number
    60895-591400
    Attorney Name
    Rebecca Liebowitz
  • Owners
Information
Mark Drawing Code
4
Mark Identification
AUTOLUS
Case File Statements
  • GS0401: Custom manufacture of therapeutic drugs, namely, cell therapies, cancer therapies and cancer vaccines
  • GS0051: Medical and veterinary preparations for therapeutic purposes for the treatment of cancer, genetic conditions, immune response disorders, autoimmune disorders, infectious diseases, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases and cardiovascular diseases; medical preparations for cell therapy for the treatment of cancer, genetic conditions, immune response disorders, autoimmune disorders, infectious diseases, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases and cardiovascular diseases; medical preparations for gene therapy for the treatment of cancer, genetic conditions, immune response disorders, autoimmune disorders, infectious diseases, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases and cardiovascular diseases; medical preparations for cancer therapies for the treatment of cancer, genetic conditions, immune response disorders, autoimmune disorders, infectious diseases, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases and cardiovascular diseases; cells for medical or clinical use, namely, cells featuring chimeric antigen receptors (CAR) and therapeutic preparations thereof for the treatment of cancer, genetic conditions, immune response disorders, autoimmune disorders, infectious diseases, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases and cardiovascular diseases; antibodies for medical purposes for the treatment of cancer, genetic conditions, immune response disorders, autoimmune disorders, infectious diseases, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases and cardiovascular diseases; preparations for genetically modifying human or animal cells for medical purposes, including viral vectors, namely, culture media for cultivating and augmentation of human and animal cells; preparations of blood extracted from humans or animals which have been adapted for therapeutic purposes; vaccines
  • GS0441: Medical services; veterinary services; medical and veterinary services in the nature of extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes, namely, medical services relating to the removal, treatment and processing of human and animal cells; medical and veterinary services in the nature of reinsertion of cells into human and animal patients; providing medical advice and consultancy in the field of medical and veterinary therapies; providing advice and consultancy in the field of cancer therapies and cancer vaccines
  • GS0421: Scientific and technological services and research and design relating thereto, namely, medical research, scientific research, analysis and testing in the field of human and animal cell, gene and cancer therapies, pharmaceutical product development, research and development of new products; industrial analysis and research services in the field of cell, gene and cancer therapies; medical and veterinary research services including the manipulation of cells within a laboratory or research facility to enable the cells to be used for therapeutic purposes; scientific research in the development of new cancer therapies; scientific research in human and animal cell therapy; scientific research in human and animal gene therapy; scientific research into vaccines, including personalised cancer vaccines; scientific research into vectors and preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services
Case File Event Statements
  • 10/5/2023 - a year ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 10/10/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 10/14/2023 - a year ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 1/25/2024 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/25/2024 - a year ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/26/2024 - a year ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 2/14/2024 - 11 months ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 2/14/2024 - 11 months ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 2/29/2024 - 11 months ago
    9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/29/2024 - 11 months ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/1/2024 - 11 months ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/5/2024 - 10 months ago
    12 - REFUSAL PROCESSED BY IB Type: RFNT
  • 3/16/2024 - 10 months ago
    13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/23/2024 - 9 months ago
    15 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/23/2024 - 9 months ago
    16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/3/2024 - 10 months ago
    14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 10/10/2024 - 3 months ago
    19 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 12/20/2024 - a month ago
    21 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 12/20/2024 - a month ago
    20 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 1/10/2025 - 18 days ago
    22 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 7/9/2024 - 6 months ago
    18 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 7/9/2024 - 6 months ago
    17 - REGISTERED-PRINCIPAL REGISTER Type: R.PR